North America Interventional Cardiology Market 2025: Industry Developments, Future Growth, Share & Industry Insights | Abbott, Canon Medical Systems, Teleflex Incorporated, B. Braun SE

The North America Interventional Cardiology Market reached US$ 7.04 billion in 2024 and is expected to reach US$ 11.98 billion by 2033, growing at a CAGR of 6.2% during the forecast period 2025-2033.

According to DataM Intelligence Comprehensive Report has released its latest report on the "North America Interventional Cardiology Market Size 2025," providing a detailed analysis of market trends, key growth drivers, competitive landscape, and regional insights. The report includes market size (value and volume), CAGR projections, and emerging opportunities that help businesses identify growth areas and build effective strategies. Backed by data-driven insights and future outlook, this study serves as a valuable resource for companies looking to stay competitive and capitalize on market potential.

Get a Free Sample Research PDF: https://datamintelligence.com/download-sample/north-america-interventional-cardiology-market?sg

Industry Latest News 2025:

✅ 03 Mar 2025: Boston Scientific Corporation announces definitive agreement to acquire SoniVie Ltd., developer of the TIVUSTM intravascular ultrasound‐based renal denervation system, to expand its interventional cardiology therapies portfolio.

✅ 27 Mar 2025: GE HealthCare launches in the U.S. the FlyrcadoTM (flurpiridaz F 18) unit‐dose PET myocardial perfusion imaging agent at the American College of Cardiology Annual Scientific Session (ACC 2025), marking a novel diagnostic tool in the cardiology pathway.

✅ 01 Jul 2025: Teleflex Incorporated completes acquisition of substantially all of BIOTRONIK SE & Co. KG's Vascular Intervention business (for ~€760 million), adding coronary and peripheral interventional device portfolio to its cath‐lab offering.

✅ 27 Oct 2025: Royal Philips introduces in the U.S./North America an industry‐first cath‐lab integration system that synchronizes pre‐operative CT imaging with C‐arm movement (Azurion + Advanced Visualization Workspace), enabling CT‐guided percutaneous coronary intervention (PCI).

✅ 25 Oct 2025: Conavi Medical announces submission to the U.S. Food & Drug Administration (FDA) of its next‐generation Novasight HybridTM intravascular imaging system (510(k) clearance sought) for the U.S. market, to support more advanced decision‐making in PCI procedures.

✅ 23 Oct 2025: Philips launches "IVUS Mentor", an AI‐powered intravascular ultrasound training and simulation system for North America, aimed at expanding interventional cardiology training globally.

Get Customization in the report as per your requirements: https://datamintelligence.com/customize/north-america-interventional-cardiology-market?sg

Market Growth Drivers:

High and rising prevalence of cardiovascular disease
Cardiovascular disorders including coronary artery disease, valvular disease, and peripheral vascular disease remain very common in North America, which creates sustained demand for interventional cardiology procedures and devices.
The aging population in the region further adds to the pool of patients requiring interventions, as older age is strongly correlated with structural and coronary heart disease.

Technological innovation and advanced devices
North America benefits from strong device development drug‐eluting stents, bioresorbable scaffolds, advanced imaging‐guided catheters (e.g., optical coherence tomography, intravascular ultrasound) and structural heart intervention tools (such as transcatheter valves) are increasingly adopted. These innovations help drive replacement demand, upgrades, and higher‐value procedures.

Growing patient awareness, screening and preventive cardiology efforts
Enhanced awareness around cardiac health, advanced diagnostics, and earlier detection of cardiovascular conditions mean more patients are being identified for intervention sooner. This increases the addressable population for interventional cardiology services and devices.

Emergence of outpatient and ambulatory procedure settings
There is increasing use of ambulatory surgical centres (ASCs) or outpatient‐based interventional procedures, which offer cost‐effective alternatives to hospitalisation. This trend expands access to interventional cardiology services, and supports device utilisation in less complex cases.

Segments Covered in the Beverage Premix Market:

By Modality (Stents, Catheters, Balloons, Guidewires, Imaging Systems, Thrombectomy Systems, Atherectomy Systems, Closure Devices, Chronic Total Occlusion Systems (CTO), Others)

By End-User (Hospitals, CATH Labs, Ambulatory Surgical Centers, Others)

Buy Now & Get 30% OFF - Grab 50% OFF on 2+ reports: https://www.datamintelligence.com/buy-now-page?report=north-america-interventional-cardiology-market?sg

Major Key Players: Medtronic, Terumo Corporation, Boston Scientific Corporation, Abbott, Canon Medical Systems Corporation, Teleflex Incorporated, B. Braun SE, Johnson & Johnson Services, Inc., Koninklijke Philips N.V., and Cook Medical.

✅ Boston Scientific Corporation: The U.S. leader in interventional cardiology devices in the U.S. market in 2024, holding dominant positions in coronary stents, balloon catheters and embolic‐protection devices.

✅ Abbott Laboratories: Ranked as the second‐largest competitor in the U.S. interventional cardiology device market in 2024, with a broad device portfolio across multiple segments and a strong position in OCT (intravascular imaging).

✅ Terumo Corporation: Identified among key global players in the interventional cardiology devices market serving the North American region, recognised for its specialty access, catheter and vascular intervention technologies.

✅ Canon Medical Systems Corporation: Listed among key participants in the North America interventional cardiology market (2024 report) alongside the major device manufacturers, underscoring its relevance in imaging and catheter‐based intervention systems.

✅ Teleflex Incorporated: Recognised globally as one of the competitive players in the interventional cardiology devices market, notably enhancing its vascular intervention portfolio through acquisitions of drug‐coated balloons and DES capabilities.

Unlimited Insights. One Subscription: https://www.datamintelligence.com/reports-subscription

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.